Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(18)30294-8
PubMed Identifier: 29908990
Publication URI: http://europepmc.org/abstract/MED/29908990
Type: Journal Article/Review
Volume: 19
Parent Publication: The Lancet. Oncology
Issue: 7
ISSN: 1470-2045